These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3291211)

  • 1. Cyclosporine coverage during the risk period leads to 100% long-term graft acceptance in the rat.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1013-5. PubMed ID: 3291211
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of long-term rat cardiac allograft survival in rats with multiple donor specific transfusions and cyclosporine.
    Perez RV; Heyd TJ; Munda R; Babcock G; Alexander JW
    Curr Surg; 1988; 45(1):9-12. PubMed ID: 3278865
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.
    Suzuki S; Enosawa S; Kakefuda T; Amemiya H; Hoshino Y; Chiba K
    Transplant Proc; 1996 Jun; 28(3):1375-6. PubMed ID: 8658701
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of low-dose cyclosporine A and multiple blood transfusions on heart graft survival in highly sensitized rats.
    de Bruin RW; Bouwman E; Heineman E; Marquet RL; Jeekel J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1094-6. PubMed ID: 3291217
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival.
    Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ
    Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term residual cyclosporine levels following short-term administration in various allograft models demonstrating extensive survival prolongation.
    Hewitt CW; Black KS; Gonzalez GA; Dowdy SF; Reyes M; Martin DC; Achauer BM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1244-5. PubMed ID: 3274310
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of kidney, composite tissue, and skin allograft survival in rats prolonged by donor blood and concomitant limited cyclosporine.
    Hewitt CW; Black KS; Stenger JA; Go C; Achauer BM; Martin DC
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1110-3. PubMed ID: 3291221
    [No Abstract]   [Full Text] [Related]  

  • 8. Postoperative bone marrow injections with cyclosporine or antithymocyte globulin in rat cardiac allografts.
    Thomas WG; Sadeghi AM; Kurlansky P; Michler RE; Smith CR; Reemtsma K; Rose EA
    Transplantation; 1986 Oct; 42(4):441-2. PubMed ID: 3532457
    [No Abstract]   [Full Text] [Related]  

  • 9. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K
    Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine regulation of blood transfusion sensitizing and enhancing potential in rabbit skin allograft recipients.
    Smit WJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1105-9. PubMed ID: 3291220
    [No Abstract]   [Full Text] [Related]  

  • 11. Identifying a susceptible period following cyclosporine A-induced tolerance of heart grafts in the rat.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1987 Oct; 19(5):4218-20. PubMed ID: 3314019
    [No Abstract]   [Full Text] [Related]  

  • 12. The synergistic effect of cyclosporine and iloprost on survival of rat cardiac allografts.
    Rowles JR; Foegh ML; Khirabadi BS; Ramwell PW
    Transplantation; 1986 Jul; 42(1):94-6. PubMed ID: 2425465
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged heart xenograft survival using combined total lymphoid irradiation and cyclosporine.
    Knechtle SJ; Halperin EC; Saad T; Bollinger RR
    J Heart Transplant; 1986; 5(3):254-61. PubMed ID: 3302172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor-specific transfusions add only in a minor degree to the effect of cyclosporine A.
    Stevens DW; Jensen CP; Jensen RM; Stevens LE
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1091-3. PubMed ID: 3291216
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of cyclosporin--A-induced graft acceptance.
    White DJ; Timmerman W; Davies HS; Nagao T; Kasahara K; Plumb A
    Transplant Proc; 1981 Mar; 13(1 Pt 1):379-82. PubMed ID: 7022857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Induction of long-term tolerance by cyclosporine in orthotopic kidney allografts in rats].
    Rodríguez J; Jiménez G; Arias J; Aller MA; Lorente L; Arias L; Arias JI; Brandau D; Durán H
    Arch Esp Urol; 1987 May; 40(4):235-40. PubMed ID: 3307645
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal transplants maintained on low-dose cyclosporine and prednisolone.
    Rogerson ME; Neild GH; Rudge CJ; Wood SM; Cairns HS; Mansell MA; Thompson FD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):114-6. PubMed ID: 3291222
    [No Abstract]   [Full Text] [Related]  

  • 19. Graft adaptation in hamster-to-rat cardiac xenografts.
    Hasan RI; Sriwatanawangosa V; Wallwork J; White DJ
    Transplant Proc; 1994 Jun; 26(3):1282-3. PubMed ID: 8029909
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyclosporin A--new perspectives in transplantation surgery].
    Margreiter R; Huber C; Borel JF
    Wien Med Wochenschr; 1983; 133 Suppl 1():37-42. PubMed ID: 6362212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.